Alignment Healthcare discloses $90,000 lobbying spend
Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash
Alignment Healthcare disclosed $90,000 in Q3 2026 lobbying expenditures focused on deregulation and Medicare rules. Insider activity over the past six months shows key executives sold more than $30 million in stock, far outpacing purchases. Institutional investors including T. Rowe Price and Bank of America substantially raised their holdings.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.